Loading clinical trials...
Loading clinical trials...
Beta-Blockers for the Prevention of Acute Exacerbations of COPD
Conditions
Interventions
Metoprolol succinate
Placebo
Locations
27
United States
Birmingham, Alabama VA Medical
Birmingham, Alabama, United States
University of Alabama at Birmingham
Birmingham, Alabama, United States
University of California, San Francisco-Fresno
Fresno, California, United States
LA BioMed at Harbor-UCLA Medical Center
Los Angeles, California, United States
University of California at San Francisco
San Francisco, California, United States
National Jewish Medical & Research Center
Denver, Colorado, United States
Start Date
May 1, 2016
Primary Completion Date
September 1, 2019
Completion Date
December 1, 2019
Last Updated
January 25, 2021
NCT06712563
NCT07518472
NCT06831994
NCT05730088
NCT02755974
NCT07363980
Lead Sponsor
University of Minnesota
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions